ESSPAND Trademark

Trademark Overview

On Thursday, October 9, 2025, a trademark application was filed for ESSPAND with the United States Patent and Trademark Office. The USPTO has given the ESSPAND trademark a serial number of 99434209. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 9, 2025. This trademark is owned by Airiver Medical, Inc.. The ESSPAND trademark is filed in the Medical Instrument Products category with the following description:

Medical device consisting of a drug delivery system, namely, a drug-coated balloon dilation device used to dilate nose anatomy and paranasal sinus ostia for the purpose of delivering pharmaceuticals
esspand

General Information

Serial Number99434209
Word MarkESSPAND
Filing DateThursday, October 9, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, October 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical device consisting of a drug delivery system, namely, a drug-coated balloon dilation device used to dilate nose anatomy and paranasal sinus ostia for the purpose of delivering pharmaceuticals

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, October 9, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAiriver Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrooklyn Park, MN 55428

Trademark Events

Event DateEvent Description
Thursday, October 9, 2025APPLICATION FILING RECEIPT MAILED
Thursday, October 9, 2025NEW APPLICATION ENTERED

Related Keywords

esspand drug device anatomy paranasal nose sinus purpose pharmaceuticals delivering dilate